TriPath Receives 510(k) for Estrogen, Progesterone Receptor Apps

May 10, 2005

TriPath Imaging and Ventana Medical Systems announced TriPath has received 510(k) clearance from the FDA for the Ventana Image Analysis System (VIAS) when used with tissues stained for Estrogen Receptor and Progesterone Receptor. As previously announced, Ventana has entered into an agreement to market globally the Ventana-branded interactive histology image analysis system from TriPath.

ArriveNet (http://press.arrivenet.com/hea/article.php/634469.html)